期刊文献+

暴发性1型糖尿病和经典自身免疫性1型糖尿病的临床特征比较研究 被引量:4

Comparison of Clinical Features between Fulminant Type 1 Diabetes and Classical Autoimmune Type 1 Diabetes
原文传递
导出
摘要 本研究回顾分析四川大学华西医院2005年10月2011年10月间收治的因酮症或酮症酸中毒入院的1 265例糖尿病患者,其中8例符合暴发性1型糖尿病(F1D)诊断标准。分析总结了该8例F1D患者的临床特征,并与16例同期以酮症酸中毒为首发症状入院,且性别、年龄匹配的经典自身免疫性1型糖尿病(T1D)患者进行病例对照研究。6年间,本院收治的F1D患者占所有酮症或酮症酸中毒入院患者的6.3‰(8/1265),年龄(30.1±9.7)岁,病程(4.0±2.4)d。8例F1D患者中,5例患者起病前出现流感样前驱症状,7例出现消化道症状。与自身免疫性T1D相比,F1D患者出现流感及消化道等前驱症状的频率更高,入院时血糖更高(P<0.01),糖化血红蛋白(HbA1c)却明显偏低(P<0.05),而空腹及餐后C肽释放水平更低,酸中毒及电解质紊乱更加严重。本研究数据显示,与自身免疫性T1D患者相比,F1D患者入院时有更复杂多变的临床症状,表现为更严重的高血糖、胰岛素缺乏及水电解质酸碱失衡。目前F1D诊断标准是否适合中国人群以及其敏感性与特异性仍亟待多中心大型临床调查进一步证实。 The data of 1,265 in-patients with diabetic ketosis or ketoacidosis treated in West China Hospital from October 2005 to October 2011 were analyzed retrospectively, and 8 of whom met fulminant type 1 diabetes (FID) diagnostic criteria. The clinical features of the 8 F1D patients were investigated and compared with other 16 newly diagnosed autoimmune type 1 diabetes (T1D) patients, gender- and age-matched and with acute onset of ketoacidosis. During the six years between 2005 and 2011, the incidence of F1D was 6.3~0 (8/1265) among all patients with dia- betic ketosis or ketoacidosis admitted to the West China Hospital. The averaged age of the patients at onset of F1D was (30.1±9.7) years old, and the duration of diabetes was (4.0±2.4) days. Five of the 8 F1D patients had flu- like symptoms, and 7 had gastrointestinal symptoms. Blood glucose of F1D patients on admission was significantly higher than that of autoimmune T1D patients (P〈0.01), while the glycated hemoglobin (HbAlc) was lower than that of autoimmune T1D patients (P〈0.01) . Additionally, fasting and postprandial C-peptide was significantly lower in F1D patients, with more severe acidosis, electrolytes and acid-base disturbances. The data suggest,that, compared with the autoimmune TID patients, F1D patients have more complicated and more severe clinical manifestation with more severe hyperglycemia, more significant insulin deficiency and more obvious fluid electrolytes and acid-base disturbances. However, the sensitivity and the specificity of the diagnostic criteria of FID are still needed to be improved for the Chinese people, so more multi-center and large-scale clinical trials should be conducted in the future.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2013年第3期597-600,610,共5页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(30600293)
关键词 暴发性1型糖尿病 酮症酸中毒 糖化血红蛋白 Fulminant type 1 diabetes (F1D) Ketoacidosis Hemoglobin (HbAlc)
  • 相关文献

参考文献19

  • 1IMAGAWA A,HANAFUSA T, MIYAGAWA J,et al. Anovel subtype of type 1 diabetes mellitus characterized by arapid onset and an absence of diabetes-related antibodies. ()-saka IDDM Study Group [J]. N Engl J Med, 2000,342(5);301-307.
  • 2IMAGAWA A, HANAFUSA T. Fulminant type 1 diabetesmellitus immunoendocrinology : scientific and clinical aspects[M]. New York: Humana Press, 2011: 331-342.
  • 3郑超,王臻,张贻宇,谭愈昱,超晨,周海峰,杨亚玲,车志宏,周智广.暴发性1型糖尿病临床流行病学调查[J].中国糖尿病杂志,2009,17(9):646-648. 被引量:29
  • 4马丽珍,俞灵莺,张楚.7例暴发性1型糖尿病与非急骤起病1型糖尿病的临床特征比较[J].浙江医学,2009,31(5):576-578. 被引量:1
  • 5IMAGAWA A, HANAFUSA T. Fulminant type 1 diabetes*-an important subtype in East Asia [J]. Diabetes Metab ResRev, 2011, 27(8):959-964.
  • 6IMAGAWA A, HANAFUSA T,UCHIGATA Y, et al.Fulminant type 1 diabetes: a nationwide survey in japan [J]. Diabetes Care, 2003, 26(8):2345-2352.
  • 7CHO Y M, KIM J T, KO K S,et al. Fulminant type 1 dia-betes in korea: High prevalence among patients with adult-onset type 1 diabetes [J]. Diabetologia,2007,50(] 1) : 2276-2279.
  • 8MOREAU C, DRUI D, ARNAULT-OUARY G, et al. Ful-minant type 1 diabetes in Caucasians: a report of three cases[J]. Diabetes Metab, 2008,34(5): 529-532.
  • 9SHAW E H,OBRIEN K E, HAYMAN R G. Fulminant de-velopment of diabetes mellitus presenting as diabetic ketoaci-dosis in a pregnant Caucasian woman [J]. Arch Dis Child Fe-tal Neonatal Ed, 2010,95(Suppl 1): Fa59.
  • 10ZHENG C,ZHOU Z, YANG L,et al. Fulminant type 1 dia-betes mellitus exhibits distinct clinical and autoimmunity fea-tures from classical type 1 diabetes mellitus in Chinese [J].Diabetes Metab Res Rev, 2011,27(1): 70-78.

二级参考文献42

  • 1周健,包玉倩,李鸣,刘芳,陈海冰,韩峻峰,陆蔚,马晓静,胡承,项坤三,贾伟平.暴发性1型糖尿病的临床特征及治疗策略探讨[J].中华糖尿病杂志,2009,1(1). 被引量:31
  • 2张弛,周智广,张冬梅,杨晓琳,周敏,林健,黄干,王建平.急骤起病伴胰酶增高的1型糖尿病临床和免疫学特征[J].中华医学杂志,2005,85(14):967-971. 被引量:46
  • 3Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med, 2000,342:301-307.
  • 4Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab,2007,3:36-45.
  • 5Imagawa A, Hanafusa T. Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud,2006,3 : 169-177.
  • 6Kawasaki E, Eguchi K. Genetics of fulminant type 1 diabetes. Ann N Y Acad Sci,2006,1079 : 24-30.
  • 7Imagawa A, Hanafusa T, Uchigata Y, et al. Different contribution of class Ⅱ HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia, 2005,48 : 294-300.
  • 8Imagawa A, Hanafusa T. Fulminant type 1 diabetes mellitus. Endocr J, 2006,53 : 577-584.
  • 9Imagawa A, Hanafusa T, Makino H, et al. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia, 2005,48: 290-293.
  • 10Iwaoka T. A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies. Endocr J,2003,50 : 225-231.

共引文献44

同被引文献42

  • 1唐晓君,卢仙娥,李革,张素华,马贵成,唐兰.2型糖尿病危险因素分析[J].中国公共卫生,2004,20(1):74-75. 被引量:26
  • 2Okumus S,Igci YZ,Taskin T,et al.Association between thr21met and ser89asn polymorphisms of the urotensin-II(UTS2)gene,diabetes mellitus,and diabetic retinopathy[J].Curr Eye Res,2012,37(10):921-929.
  • 3全国糖尿病研究协作组调查研究组.全国14省市糖尿病调查报告[J].中华内科杂志,2009,20(11):678-831.
  • 4Metzger BE,Coustan D.Summary and recommendations of the fourth international workshop conference on gestational diabetes mellitus[J].Diabetes Care,1998,21(2):161-167.
  • 5Simsek E,Binay ?,Flanagan SE,et al.Congenital hyperinsulinism presenting with different clinical,biochemical and molecular genetic spectra[J].Turk J Pediatr,2014,55(6):584-590.
  • 6Amencan Diabetes Association.Standards of medical care in diabetes—2011[J].Diabetes Care,2011,34(Sup1):4-10.
  • 7Rezvan N,Hosseinzadeh-Attar MJ,Masoudkabir F,et al.Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy[J].Arch Gynecol Obstet,2012,285(5):1257-1262.
  • 8Brown SA,Garc AA,Winter M,et al.Integrating education,group support,and case management for diabetic Hispanics[J].Ethn Dis,2011,21(1):20-26.
  • 9Zhang J,Zhang K,Gao ZG,et al.Agonist-bound structure of the human P2Y12 receptor[J].Nature,2014,509(7498):119-122.
  • 10Gonzalez S,Binato R,Guida L,et al.Conserved transcription factor binding sites suggest an activator basal promoter and a distal inhibitor in the galanin gene promoter in mouse ES cells[J].Gene,2014,538(2):228-234.

引证文献4

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部